This site might not work as expected.
You're using an old browser that isn't supported by this site. Please upgrade or download one of these free and excellent browsers:

Wavefront Optics Emerging as New Tool for Measuring and Correcting Vision, Reports Optometry and Vision Science

Update on New Clinical Applications for Assessing 'Higher-Order' Visual Abnormalities

​A technique developed by astronomers seeking a clear view of distant objects in space is being intensively studied as a new approach to measuring and correcting visual abnormalities.  The October issue of  Optometry and Vision Science, official journal of the  American Academy of Optometry, is a theme issue devoted to research on wavefront refraction and correction.  The journal is published by  Lippincott Williams & Wilkins, a part of  Wolters Kluwer Health.

The special issue presents new research on the use of wavefront analysis for assessing subtle, "higher-order aberrations" in vision.  Anthony Adams, OD, PhD, Editor-in-Chief of Optometry and Vision Science, comments:  "We are now at the stage where clinicians are looking for the advantages to their patients, and clinical researchers are trying to evaluate the clinical advantages in vision with correction of these aberrations, beyond the prescriptions that have served us so well for over 100 years."

Wavefront Analysis—From Telescopes to Your Optometrist's Office
The 16 original papers in the special issue emphasize the emerging clinical uses of wavefront analysis in optometry.  The theme issue was assembled by a distinguished group of nine guest editors, leaders in research on optical wavefront measurement and their potential applications to vision correction. 

The science of wavefront optics originated in astronomy, as a means of measuring and correcting for atmospheric distortion in the images of stars.  Over the past two decades, optometry researchers have been exploring the use of wavefront analysis to assess the higher-order aberrations (abnormalities) that exist in all eyes.

The special issue provides an overview of what's going on now in the "global deployment" of wavefront analysis techniques.  Wavefront aberrometry shows promise for assessing and treating a wide range of challenging optical problems, such as cataracts, diabetic eye disease, and corneal refractive surgery.

Optometrists in some settings are already using these techniques to define a wide range of optical abnormalities—beyond the conventional myopia, hyperopia (nearsightedness and farsightedness), and astigmatism.  Clinical research has led to some success in prescribing new types of correction for these higher-order visual aberrations.

New Techniques May Enable 'Objective, Comprehensive' Objective Vision Assessments
Research using wavefront analysis is also helping optometrists to better understand a wide range of issues encountered in everyday practice, including changes in functional vision associated with aging, wearing glasses, and other conditions.  Growing clinical experience is questioning some past assumptions, leading to further refinements in the science of wavefront optics.

So far, the greatest successes in clinical use of wavefront analysis have been in correction of eye diseases associated with extensive visual defects—for example, keratoconus, a distortion of the cornea.  In some cases, visual correction for eyes with subtle abnormalities detected by wavefront analysis needs to be custom-designed, raising challenges for the development of corrective devices.

As the clinical applications of wavefront analysis continue to mature, "There is a sense that we may be approaching a time when it is no longer necessary to ask the patient, 'Which lens is better, number one or number two?'" according to Dr. Adams.  Rapidly developing technologies are providing "reliable, objective, and comprehensive" measurements for guiding and monitoring visual correction.  Dr. Adams adds, "Reliable optical measurements will, in turn, allow the clinician to concentrate on other, equally important aspects of treatment like effectiveness, comfort, convenience, cost, and availability."

Click here to read the October issue of Optometry and Vision Science.

About Optometry and Vision Science
Optometry and Vision Science, official journal of the  American Academy of Optometry, is the most authoritative source for current developments in optometry, physiological optics, and vision science. This frequently cited monthly scientific journal has served primary eye care practitioners for more than 75 years, promoting vital interdisciplinary exchange among optometrists and vision scientists worldwide.

About the American Academy of Optometry
Founded in 1922, the  American Academy of Optometry is committed to promoting the art and science of vision care through lifelong learning.  All members of the Academy are dedicated to the highest standards of optometric practice through clinical care, education or research.

About Wolters Kluwer Health
Wolters Kluwer Health is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Serving more than 150 countries worldwide, clinicians rely on Wolters Kluwer Health's market leading information-enabled tools and software solutions throughout their professional careers from training to research to practice. Major brands include  Health Language ®Lexicomp ®Lippincott Williams & WilkinsMedicom®Medi-Span ®MedknowOvid ®Pharmacy OneSource®ProVation ® Medical and  UpToDate ®.

Wolters Kluwer Health is part of  Wolters Kluwer, a market-leading global information services company. Wolters Kluwer had 2013 annual revenues of €3.6 billion ($4.7 billion), employs approximately 19,000 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Wolters Kluwer is headquartered in Alphen aan den Rijn, the Netherlands. Its shares are quoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

Follow our official Twitter handle:  @WKHealth.